Crinetics Pharmaceuticals Inc. (CRNX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Crinetics Pharmaceuticals...

    NASDAQ: CRNX · Real-Time Price · USD
    30.99
    0.34 (1.11%)
    At close: Aug 29, 2025, 3:59 PM
    30.99
    0.00%
    After-hours: Aug 29, 2025, 04:38 PM EDT

    Crinetics Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -13.84 -9.63 -5.8 -10.14
    PEG Ratio
    		 n/a -0.56 -0.46 -0.65
    PS Ratio
    		 3.98K 514.87 200.82 1.01K
    PB Ratio
    		 3.12 3.83 3.01 3.29
    P/FCF Ratio
    		 -17.97 -12.08 -8.14 -12.27
    P/OCF Ratio
    		 -18.28 -12.42 -8.26 -12.33
    OCF/S Ratio
    		 -217.49 -41.44 -24.32 -82.18
    Debt / Equity Ratio
    		 0.04 0.10 0.01 0.01
    Quick Ratio
    		 23.04 13.07 12.45 21.68
    Current Ratio
    		 23.04 13.07 12.45 21.55
    Asset Turnover
    		 0.00 0.01 0.01 0.00
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.23 -0.4 -0.52 -0.32
    Return on Assets
    		 -0.21 -0.34 -0.47 -0.31
    Return on Invested Capital
    		 -0.24 -0.37 -0.51 -0.32
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 0.71 -0.17
    Net Profit Margin
    		 -287.21 -53.46 -34.6 -99.85
    Pretax Profit Margin
    		 -287.21 -53.46 -34.6 -99.85
    Operating Profit Margin
    		 -326.13 -55.47 -35.44 -99.91
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 -326.13 -55.2 -35.23 -99.05

    Add to Watchlist